Table 2.
Self-reported chemosensory alterations by age group and gender during and 3–7 months following COVID-19 (n = 704)
| During acute COVID-19 | 3–7 months after COVID-19 | ||||||
|---|---|---|---|---|---|---|---|
| Olfaction | Gustation | Trigeminal | Olfaction | Gustation | Trigeminal | ||
| Age | Gender | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) |
| 18–29 | M (N = 11) | 9 (81.8) | 9 (81.8) | 4 (36.4) | 6 (54.5) | 5 (45.5) | 3 (27.3) |
| F (N = 115) | 106 (92.2) | 106 (92.2) | 54 (47.0) | 68 (59.1) | 55 (47.8) | 16 (13.9) | |
| 30–39 | M (N = 26) | 23 (88.5) | 21 (80.8) | 12 (46.2) | 13 (50.0) | 7 (26.9) | 4 (15.4) |
| F (N = 153) | 133 (86.9) | 129 (84.3) | 77 (50.3) | 83 (54.2) | 63 (41.2) | 37 (24.2) | |
| 40–49 | M (N = 33) | 23 (69.7) | 23 (69.7) | 13 (39.4) | 12 (36.4) | 9 (27.3) | 5 (15.2) |
| F (N = 165) | 142 (85.5) | 137 (83.0) | 83 (50.3) | 97 (58.8) | 77 (46.7) | 42 (25.5) | |
| 50–59 | M (N = 28) | 13 (46.4) | 14 (50.0) | 9 (32.1) | 7 (25.0) | 7 (25.0) | 4 (14.3) |
| F (N = 128) | 100 (78.1) | 102 (79.7) | 66 (51.6) | 62 (48.4) | 57 (44.5) | 39 (30.5) | |
| 60+ | M (N = 13) | 5 (38.5) | 6 (46.2) | 5 (38.5) | 2 (15.4) | 1 (7.7) | 3 (23.1) |
| F (N = 32) | 19 (59.4) | 27 (84.4) | 15 (46.9) | 16 (50.0) | 14 (43.8) | 11 (34.4 | |
| Total (N = 704) | 572 (81.3) | 574 (81.5) | 338 (48.0) | 366 (52.0) | 295 (41.9) | 164 (23.2) |